Showing 31 - 40 of 86
India cases surge; CDC's J&J talk ends without vote: Virus update
Bloomberg News, Published on 15/04/2021
» India reported more than 200,000 new infections on Thursday, its highest one-day surge since the pandemic broke out. A Centers for Disease Control and Prevention panel ended discussion of the Johnson & Johnson vaccine without taking a vote, while J&J itself said it continues to believe in the positive benefit-risk profile of its Covid-19 shot.
Worst Covid surge in SE Asia hammers Philippine hospitals
Bloomberg News, Published on 06/04/2021
» As hospitals in the Philippine capital reach capacity from a new surge of coronavirus cases, increasingly desperate Filipinos are stocking up on oxygen tanks and touting unapproved medications amid fears the health care system may collapse.
J&J vaccine manufacturing error affects 15m doses
Bloomberg News, Published on 01/04/2021
» A manufacturing error at a plant involved in Covid-19 vaccine production affected 15 million doses worth of an ingredient for Johnson & Johnson’s vaccine, according to two people familiar with the matter, though the company downplayed the situation and said it met its most recent vaccine delivery target.
FDA approves Johnson & Johnson vaccine
Bloomberg News, Published on 25/03/2021
» Thailand cleared Johnson & Johnson’s single-shot Covid-19 vaccine for local emergency use, the third manufacturer to win the approval.
Astra vaccine fears grow over clot concerns
Bloomberg News, Published on 15/03/2021
» AstraZeneca Plc’s vaccine for Covid-19, once expected to be a mainstay of protection for much of the world, remains shrouded in controversy as more countries limit its use even as scientists warn of the need for governments to tread carefully.
Thai vaccine human trials to begin in March
Bloomberg News, Published on 10/02/2021
» Thailand will begin clinical trials of a locally developed Covid-19 vaccine in March, making it the nation’s first inoculation programme to enter human trials.
China’s CanSino Covid vaccine shows 65.7% efficacy
Bloomberg News, Published on 09/02/2021
» CanSino Biologics Inc’s experimental coronavirus vaccine has an efficacy rate of 65.7% at preventing symptomatic cases based on an analysis from late-stage trials, adding a one-shot candidate to the world’s growing arsenal against Covid-19.
Stark differences among SE Asia’s vaccination strategies
Bloomberg News, Published on 08/02/2021
» Moderna Inc won approval from Singapore for its Covid vaccine and signed a deal to sell doses to the Philippines, becoming the fourth supplier to get regulatory clearance in Southeast Asia.
China’s Sinovac steps up defence of vaccine after confusing data
Bloomberg News, Published on 18/01/2021
» China’s Sinovac Biotech Ltd defended the efficacy of its Covid-19 shot, saying the vaccine that’s being rolled out from Indonesia to Brazil despite inconsistent data readouts is more effective in preventing the disease if the two-dose regime is administered over a longer time frame.
Indonesia starts nationwide Sinovac vaccine distribution
Bloomberg News, Published on 03/01/2021
» Indonesia will start distributing the vaccine developed by China’s Sinovac Biotech Ltd to all its 34 provinces on Sunday, Kompas reported.